Cactus Botanicals launch 80 percent myricetin

By staff reporter

- Last updated on GMT

Related tags: Chromatography, High performance liquid chromatography

Cactus Botanicals is introducing a potent 80 percent myricetin
ingredient from bayberry bark for use in supplements in the United
States.

The dry extract is 100 percent water-soluble, at 80 percent tested HPLC (high-performance liquid chromatography). The category of flavonoids as a whole has been gaining increasing clout as the body of scientific literature behind it grows - which in turn should make it easier for Cactus Botanicals to market this concentration of the extract. These flavonoids are associated with lowering the risk of prostate cancer and lowering high cholesterol levels. Myricetin are found in food sources such as berries, vegetables and herbs, but Cactus Botanicals' extract is sourced from the bark myrica cerifera. The company said myricetin is commonly marketed as an ingredient in products designed to help consumers stop smoking as it is believed the compound blocks certain enzymes within the body. Myricetin is also considered to be an antioxidant, ridding the body of cancer causing free radicals. Historical uses of myricetin, according to Cactus Botanicals, include treatments for diarrhea, dysentery and fevers. Cactus Botanicals is based in the United Kingdom, with operations in China as well.

Related news

Show more

Related products

show more

Does my Nutraceutical Need a Clinical Trial?

Does my Nutraceutical Need a Clinical Trial?

dicentra – CRO and regulatory consulting firm | 03-Aug-2020 | Technical / White Paper

The global nutraceutical industry is growing at an unprecedented rate. However, companies preparing to bring new and innovative products to the burgeoning...

Supporting cardiovascular health with probiotics

Supporting cardiovascular health with probiotics

Deerland Probiotics & Enzymes | 03-Aug-2020 | Technical / White Paper

Throughout the last decade, researchers have investigated the role of the gut microbiota in the development of cardiovascular disease. Evidence exists...

Related suppliers

Follow us

Products

View more

Webinars